Granisetron HCl 1 mg Oral Tablet
RxNorm 310599
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 310599 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: granisetron HCl 1 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Granisetron 1 mg Oral Tablet
(Atom ID: 12340777)
PTPrescribable
Designated preferred name (PT):
Granisetron (as granisetron hydrochloride) 1 mg oral tablet
(Atom ID: 10299365)
SYPrescribable
Synonym (SY):
Granisetron 1 mg (granisetron hydrochloride 1.12 mg) Oral Tablet
(Atom ID: 3264219)
PSNPrescribable
Prescribable Name (PSN):
Granisetron HCl 1 mg Oral Tablet
(Atom ID: 7739323)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely granisetron (as granisetron hydrochloride) 1 mg/1 each conventional release oral tablet (clinical drug)
(Atom ID: 10313125)
Patient Education
Granisetron
Granisetron is used to prevent nausea and vomiting caused by cancer chemotherapy and radiation therapy. Granisetron is in a class of medications called 5-HT3 receptor antagonists. It works by blocking serotonin, a natural substance in the body that causes nausea and vomiting.
[Learn More]
* Please review the disclaimer below.